Respiratory stimulant use in chronic obstructive pulmonary disease

Annals of Pharmacotherapy

Volumn 38, Issue 10, 2004, Pages 1722-1725

  Bales, Melissa J ^a,b   Timpe, Erin M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Walmart Pharmacy   (United States)

Author keywords

Acetazolamide; Chronic obstructive pulmonary disease; Medroxyprogesterone acetate

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; MEDROXYPROGESTERONE ACETATE; RESPIRATORY STIMULANT AGENT;

ARTERIAL GAS; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDICATION; DYSPNEA; EMBASE; EVALUATION; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LUNG VENTILATION; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATION CONTROL; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTEMATIC REVIEW;

ACETAZOLAMIDE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY SYSTEM AGENTS;

EID: 4644301496     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E039     Document Type: Review

References (12)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveillance Summaries 2002;51:1-16.
2. Konzem SL, Stratum MA. Chronic obstructive lung disease. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy. 5th ed. New York: McGraw-Hill, 2002:511-29.
3. Wagenaar M, Vos P, Heijdra Y, Teppema L, Folgering H. Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD. Chest 2003;123:1450-9.
4. Cooper C, Howard P. An analysis of sequential physiologic changes in hypoxic cor pulmonale during long-term oxygen therapy. Chest 1991; 100:76-80.
5. Cooper C, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax 1987;42:105-10.
6. Medical Research Council. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet 1981;1:681-6.
7. Strom K, Boe J, Boman G, Skoogh BE. Expectations of benefit from long-term oxygen therapy. Eur Respir Rev 1991;1:541-9.
8. Bayliss DA, Millhorn DE. Central neural mechanisms of progesterone action: application to the respiratory system. J Appl Physiol 1992;73: 393-404.
9. 2 retention during sleep in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1981;124:260-8.
10. Swenson ER. The respiratory aspects of carbonic anhydrase. Ann N Y Acad Sci 1984;429:547-60.
11. Wagenaar M, Vos PJ, Heijdra YF, Teppema LJ, Folgering HTM. Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients. Eur Respir J 2002;20:1130-7.
12. Skatrud JB, Dempsey JA. Relative effectiveness of acetazolamide versus medroxyprogesterone acetate in correction of chronic carbon dioxide retention. Am Rev Respir Dis 1983;127:406-12.